Jubilant Pharmova informs about USFDA communication

27 Aug 2022 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that it enclosed a press release pertaining to receipt of Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the USFDA for radiopharmaceuticals manufacturing facility of subsidiary company Jubilant Draximage Inc., at Montreal Canada. 

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

1074.30 7.05 (0.66%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×